Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
Precision or personalized healthcare is revolutionizing how medicine is practiced today. Scientific advances have identified a wealth of genetic and protein biomarkers that can be used to identify and associate certain disease states with specific individuals, and now can also predict how patients will respond to particular drugs. To date there are over 85 companion diagnostic FDA approved tests on the market and 500 identified biomarkers. With this diagnostic and prognostic potential, personalized medicine has hit the healthcare industry by...
View full press release